Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001869162 | SCV002239077 | pathogenic | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2023-03-30 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 633665). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CACNA1S-related conditions. This variant is present in population databases (rs757045433, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Leu1330Trpfs*94) in the CACNA1S gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CACNA1S are known to be pathogenic (PMID: 26247046, 28012042). |
Gharavi Laboratory, |
RCV000782225 | SCV000920712 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |